Moreover, some medications induce myeloid differentiation in AML cells via MEK/ERK-mediated increase in the protein levels of C/EBPβ, C/EBPε and PU.1 [12, 13, 17, 18]. The gene discussed is MAP2K7; the disease is acute myeloid leukemia.